Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; mouse; loading ...
| Neumann S, Campbell K, Woodall M, Evans M, Clarkson A, Young S. Obesity Has a Systemic Effect on Immune Cells in Naïve and Cancer-Bearing Mice. Int J Mol Sci. 2021;22: pubmed publisher
|
- flow cytometry; mouse; 8 ug/ml; loading ...; fig 1c
| Shih Y, Liu M, Kwon S, Iida M, Gong Y, Sangaj N, et al. Dysregulation of ectonucleotidase-mediated extracellular adenosine during postmenopausal bone loss. Sci Adv. 2019;5:eaax1387 pubmed publisher
|
| del Rio M, de Juan C, Roncador G, Caleiras E, xc1 lvarez Esteban R, P xe9 rez Sim xf3 n J, et al. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression. Front Immunol. 2023;14:1113858 pubmed publisher
|
| Wang B, Chen J, Caserto J, Wang X, Ma M. An in situ hydrogel-mediated chemo-immunometabolic cancer therapy. Nat Commun. 2022;13:3821 pubmed publisher
|
| Fang F, Cao W, Mu Y, Okuyama H, Li L, Qiu J, et al. IL-4 prevents adenosine-mediated immunoregulation by inhibiting CD39 expression. JCI Insight. 2022;7: pubmed publisher
|
| Xiao Y, Chen J, Zhou H, Zeng X, Ruan Z, Pu Z, et al. Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy. Nat Commun. 2022;13:758 pubmed publisher
|
| Smith A, Knochelmann H, Wyatt M, Rangel Rivera G, Rivera Reyes A, Dwyer C, et al. B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity. J Immunother Cancer. 2022;10: pubmed publisher
|
| Zheng Y, Chen Z, Zhou B, Chen S, Han L, Chen N, et al. PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1+CD8+ Terminal Effector T Cells and Promotes Cancer Development. J Immunol. 2022;208:501-513 pubmed publisher
|
| Luna Yolba R, Marmoiton J, Gigo V, Marechal X, Boet E, Sahal A, et al. Disrupting Mitochondrial Electron Transfer Chain Complex I Decreases Immune Checkpoints in Murine and Human Acute Myeloid Leukemic Cells. Cancers (Basel). 2021;13: pubmed publisher
|
| Zhu W, Zhao Z, Feng B, Yu W, Li J, Guo H, et al. CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer. Onco Targets Ther. 2021;14:2149-2161 pubmed publisher
|
| Watson M, Vignali P, Mullett S, Overacre Delgoffe A, Peralta R, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645-651 pubmed publisher
|
| Wang J, Xu Y, Chen Z, Liang J, Lin Z, Liang H, et al. Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia. Cell. 2020;183:1867-1883.e26 pubmed publisher
|
| Huang B, Chen Z, Geng L, Wang J, Liang H, Cao Y, et al. Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways. Cell. 2019;179:1160-1176.e24 pubmed publisher
|
| Silva M, Davoli Ferreira M, Medina T, Sesti Costa R, Silva G, Lopes C, et al. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis. Nat Commun. 2018;9:1513 pubmed publisher
|